Jinhua Zhang is the founder of IASO Biotherapeutics. IASO Biotherapeutics has raised $120M in total funding. Latest round: Series B.
Jinhua Zhang established IASO Biotherapeutics in March 2017 and serves as the company's Chairman and Chief Executive Officer. She has led the company through multiple financing rounds and advanced its BCMA CAR-T therapy CT103A into a Phase 2 Pivotal trial.
Full founder directory · Investor directory · Company funding database · Fundraising library